Human TAF13(Transcription initiation factor TFIID subunit 13) ELISA Kit

The Human TAF13 (Transcription Initiation Factor TFIID Subunit 13) ELISA Kit is a highly sensitive and specific assay designed to detect and quantify TAF13 protein levels in human serum, plasma, and cell lysates. TAF13 is a subunit of the TFIID complex, which is essential for the initiation of transcription by RNA polymerase II. Dysregulation of TAF13 expression has been implicated in various diseases, including cancer, making it an important biomarker for disease diagnosis and prognosis.

The ELISA kit utilizes a sandwich enzyme-linked immunosorbent assay format, in which TAF13 protein is captured by a specific antibody coated on a microplate and detected by a second antibody conjugated to horseradish peroxidase. The assay has a detection range of 0.156-10 ng/mL and a sensitivity of 0.078 ng/mL, allowing for the accurate quantification of TAF13 protein levels in biological samples. The kit includes all necessary reagents and controls, making it easy to use and highly reproducible.

The Human TAF13 ELISA Kit is a valuable tool for researchers and clinicians studying the role of TAF13 in disease pathogenesis and progression. It can be used to screen large numbers of samples quickly and accurately, providing valuable insights into the molecular mechanisms underlying disease. The kit is also suitable for monitoring TAF13 protein levels in response to therapeutic interventions, allowing for the development of personalized treatment strategies. Overall, the Human TAF13 ELISA Kit is a reliable and versatile assay that can be used in a wide range of applications in both basic and clinical research.